During ESMO 2023, GI oncologists came together to discuss gastrointestinal cancer data emerging from the congress and the potential implications for clinical practice in the EU and China.

The meeting co-chairs each shared selected abstracts presented during ESMO before opening up the discussion to the panel of experts, including two GI CONNECT members, Prof. Dominik Modest and Prof. Hans Prenen. Watch the on-demand video to hear what they had to say.

Panel

  • Prof. Rui-Hua Xu, Sun Yat-sen University Cancer Center, Guangzhou, China
  • Prof. Gong Chen, Sun Yat-sen University Cancer Center, Guangzhou, China
  • Prof. Dr Dominik Modest, Charité - Universitätsmedizin Berlin, Germany
  • Prof. Dr Hans Prenen, University Hospital Antwerp, Belgium

Clinical Takeaways

  • In the KEYNOTE-811 trial, pembrolizumab added to first-line trastuzumab and chemotherapy significantly improves PFS and response rates in HER2+ metastatic gastric cancer/gastroesophageal junction cancer (mGC/GEJC), especially in those with PD-L1 overexpression, versus placebo.
  • In the interim analysis of the MATTERHORN study, peri-operative durvalumab with FLOT in resectable GC/GEJC demonstrates a significant increase in complete response rates and downstaging, versus placebo.
  • In the CodeBreaK 300 study, sotorasib (especially at 960 mg) in combination with panitumab improves PFS and response rates in chemorefractory mCRC, as compared to standard of care.
  • The final analysis of the RATIONALE-305 study showed that tislelizumab in combination with chemotherapy improves overall survival in patients with advanced or metastatic GC/GEJC, as compared to placebo plus chemotherapy.

Trials

  • KEYNOTE-811
  • MATTERHORN
  • RATIONALE-305
  • CODEBREAK 300
  • CAIRO5
  • PEGASUS

 

  • Inform oncologists about the latest clinical insights in GI oncology presented during EMSO 2023
  • Understand the impact of the latest clinical insights on clinical practice in the EU and China 

Programme summary
  • clock Duration 50 MIN
  • clock HCPs enrolled 1007 HCPs
  • clock Language(s) flag
Play the video now
Share this programme
This educational programme is supported by an Independent Medical Education Grant from BeiGene Europe and SystImmune.
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI CONNECT

GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer and BeiGene Europe.

Meet the experts

Other programmes of interest

podcast Podcast
Oncology 
Prostate cancer: Pre-analytical phase challenges and biomarker testing

Moderated by the Oncology Brothers. Episode 1 of a 3-part video podcast series

Experts
Dr Alexander Wyatt, Dr Petros Grivas, Oncology Brothers (Moderators)
Endorsed by
AMP
  • download Downloadable
    Resouces
  • clock 30 MIN
  • calendar Nov 2023

Educational programme supported by an independent medical education grant from AstraZeneca and Amoy Diagnostics.
interactive-patient-case Interactive patient case

Episode

2

of 2

episode
Oncology 
Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer – Part 2

An interactive patient case video series from breast cancer specialists

Experts
Prof. Valentina Guarneri
Endorsed by
GRASP
  • clock 15 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from Menarini Stemline Oncology
conference-update Conference update
Oncology 
RCC Update from ESMO 2023

How will the latest data impact clinical practice?

Experts
Prof. Laurence Albiges
  • download Downloadable
    Resouces
  • clock 4 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from Eisai Europe Limited.
conference-update Conference update
Oncology 
Lung cancer highlights from ESMO 2023

An expert panel discussion hosted by eChinaHealth and COR2ED

  • clock 43 MIN
  • calendar Oct 2023

This educational programme is supported by an Independent Medical Education Grant from SystImmune and BeiGene Europe.
conference-update Conference update
Oncology 
Precision Oncology Update From ESMO 2023

How will the latest data impact clinical practice?

Experts
Dr Philipp Ivanyi
  • download Downloadable
    Resouces
  • clock 3 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from Bayer.
video Video
Oncology 
Navigating the ER+ Breast Cancer Journey: Oral SERDs and the Treatment Landscape

Follow a patient's breast cancer journey from diagnosis to treatment options

Experts
Prof. Francois-Clement Bidard
Endorsed by
GRASP
  • download Downloadable
    Resouces
  • clock 7 MIN
  • calendar Oct 2023

Educational programme supported by an independent medical education grant from Menarini Stemline Oncology.